Breast cancer clinical trials
2,825 studies are looking for volunteers right now. Search near you to see which are close by and who can take part.
Or see all breast cancer studies in TrialFinder. Live data from ClinicalTrials.gov, updated daily.
At a glance
Where the studies are
U.S. states with the most recruiting breast cancer studies. A study counts once in each state where it has a site.
- California355
- New York352
- Texas352
- Florida304
- Massachusetts224
- Pennsylvania214
- Ohio204
- Tennessee200
- Illinois198
- North Carolina194
- Virginia193
- Michigan183
Also in China (727), France (245), Italy (231), Spain (185), Canada (172), South Korea (141), Germany (139), United Kingdom (124).
Types of study
Phases 1 to 4 test medicines, from first safety checks to long-term follow-up after approval. Trials of devices and programs have no phase. Observational studies give no study treatment.
- Early phase 136
- Phase 1215
- Phase 1 / Phase 2186
- Phase 2555
- Phase 2 / Phase 326
- Phase 3232
- Phase 441
- No phase (devices, programs)849
- Observational685
Recently updated studies
Recruiting breast cancer studies whose listing changed most recently. Open one in TrialFinder to check if you might qualify.
- RecruitingPhase 3NCT07441681
Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Advanced Head and Neck Cancer Who Cannot Receive Cisplatin
Ages 18 Years and over · Birmingham, Alabama · Anaheim, California +117 more · NRG Oncology
- RecruitingPhase 3NCT06422143
Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]
Ages 18 Years and over · Little Rock, Arkansas · Burbank, California +186 more · Merck Sharp & Dohme LLC
- RecruitingPhase 3NCT04267848
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Ages 18 Years and over · Anchorage, Alaska · Fairbanks, Alaska +749 more · National Cancer Institute (NCI)
- RecruitingPhase 3NCT06170788
Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)
Ages 18 Years and over · Phoenix, Arizona · Burbank, California +188 more · Merck Sharp & Dohme LLC
- RecruitingObservationalNCT07899099
Mecapegfilgrastim for Prevention of Chemotherapy-Induced Neutropenia in Advanced Breast Cancer
Ages 18 Years and over · Hangzhou, Zhejiang · Zheng Yabing
- RecruitingNo phase (devices, programs)NCT07706556
Pilot SMART of a Remotely Delivered, Physical Activity Intervention for Breast Cancer Survivors
Ages 18 Years and over · Lebanon, New Hampshire · Dartmouth-Hitchcock Medical Center
- RecruitingNo phase (devices, programs)NCT07233863
Lymphovenous Bypass Procedure for Secondary Prevention of Lymphedema in Breast Cancer
Ages 18 Years and over · Jakarta, Jakarta Special Capital Region · Dharmais National Cancer Center Hospital
- RecruitingPhase 3NCT04181060
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Ages 18 Years and over · Anchorage, Alaska · Fairbanks, Alaska +426 more · National Cancer Institute (NCI)
Worth knowing
- Taking part is your choice, and you can stop at any time.
- Each study has rules about who can join. The study team checks them with you before you start.
- Talk to your doctor about whether a study is a good fit for you.